2026-04-14T03:55:18Zhttps://recercat.cat/oai/requestoai:recercat.cat:20.500.14342/51792025-05-15T19:19:58Zcom_2072_482405com_2072_183628col_2072_482409
RECERCAT
author
Peroy-Badal, Renata
author
Sevillano-Castaño, Ana
author
Núñez-Cortés, Rodrigo
author
García-Fernández, Pablo
author
Torres Castro, Rodrigo
author
Vilaro, Jordi
author
Blanco, Isabel
author
Gimeno-Santos, Elena
2025-05-15T19:19:57Z
2025-05-15T19:19:57Z
2022-12
http://hdl.handle.net/20.500.14342/5179
https://doi.org/10.3390/ healthcare11010051
Many people recovering from an acute episode of coronavirus disease (COVID-19) experience prolonged symptoms. Exercise testing is a feasible and cost-effective option for assessing exercise tolerance, fatigue, and dyspnea related to effort. Being that the Chester step test (CST) is a progressive, submaximal test for predicting aerobic capacity, it could be a good option to explore. This study aimed to determine the reproducibility of CST for assessing exertional desaturation and exercise capacity in patients post-COVID-19 disease. A cross-sectional study was conducted on post-COVID-19 patients. Two attempts of the CST were performed. The intraclass correlation coefficient (ICC) was used to assess agreement between the two tests. Forty-two symptomatic post-COVID-19 patients were included, the mean age was 53.8 ± 10.3 years, and 52% were female. There was no significant difference between both tests (p = 0.896). Twenty-four percent of participants (10 cases) had a clinically significant decrease in SpO2 at the first assessment, compared to 30.1% (13 cases) at the second, with no significant difference. An ICC of 0.993 (95% CI: 0.987 to 0.996) was obtained for the total number of steps in the CST.
eng
© L'autor/a Attribution 4.0 International
COVID-19 (Malaltia)
Chester Step Test (CST)
Rendiment (Esports)
Exercici
Rehabilitació
The Chester step test is a reproducible tool to assess exercise capacity and exertional desaturation in post-COVID-19 patients
info:eu-repo/semantics/article